Corganics, a clinical cannabinoid (CBD) company, announced a patient access partnership with OrthoLoneStar, an independent orthopedic practice in Texas. The partnership provides OrthoLoneStar patients access to Corganics' clinical CBD therapies throughout OrthoLoneStar's locations.
OrthoLoneStar is an integrated private practice group comprised of more than 1150 employees and 169 physicians treating patients at 46 sites across Texas. OrthoLoneStar physicians treat the full range of orthopedic issues in its Advanced Orthopaedics and Sports Medicine, Carrell Clinic, Azalea Orthopedics, Texas Orthopedic Associates and Fondren Orthopedic Group locations.
"OrthoLoneStar cares deeply about the quality and safety of therapy options for our patients," stated Anthony Brooks, CEO of OrthoLoneStar. “We have partnered with Corganics to provide access to cannabinoid therapy that is high quality and independently tested to ensure potency, transparency and consistency."
Corganics' products are third-party tested in ISO-certified labs and manufactured in a cGMP compliant and NSF certified facility. Corganics' clinical CBD therapy products also contain no detectable THC and can only be purchased directly through healthcare professionals or with a referral from their healthcare professional.
"Patients are treating themselves with retail CBD products that may or may not have the advertised content," stated Robert Scheinberg, M.D., orthopedic surgeon and member of the OrthoLoneStar board of directors. "They deserve access to a product that is safer, higher quality and cleaner than current retail versions."
Benzinga's Cannabis Capital Conference Is Back
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.
Photo by CRYSTALWEED cannabis on Unsplash
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.